The daughter of a woman who allegedly died from Eliquis use is filing an Eliquis wrongful death lawsuit against the makers of the blood thinning drug.

Plaintiff Catherine S. is filing an Eliquis wrongful death lawsuit on behalf of her mother, Margaret S. Margaret began taking Eliquis for her atrial fibrillation in May 2015.

Margaret was in a skilled nursing facility recovering from pneumonia and atrial fibrillation. In June 2015, Catherine says, Margaret was found in her bed with blood coming from her mouth and nose. Medical professionals also found copious amounts of blood in a trash can nearby.

Margaret was in cardiac arrest and CPR was begun. An ambulance was called and she was taken to the hospital, according to this Eliquis wrongful death lawsuit.

At the hospital it was determined that she had suffered irreversible brain damage from the cardiac arrest. At this point, her family decided to remove Margaret from life support, and she subsequently died.

Because Catherine, her daughter, believes her mother’s death was caused by Eliquis, she holds the drug’s makers responsible. Catherine says she has endured and will continue to endure emotional and mental anguish, medical and funeral expenses, as well as other economic and non-economic damages.

Catherine claims that Bristol-Myers Squibb and Pfizer are guilty of design defect, failure to warn, negligence and gross negligence, fraud and fraudulent concealment, breach of warranties and Eliquis wrongful death.

The plaintiff alleges that Eliquis is inherently unsafe, defective and dangerous and poses an unreasonable danger to those who take Eliquis. Allegedly, Eliquis is more likely to cause serious bleeding that can be irreversible and permanently disabling than similar anticoagulants and poses a greater risk to those patients in a certain age and weight class.

She believes that Pfizer and Bristol-Myers Squibb put Eliquis on the market with wanton and reckless disregard for public health. According to this Eliquis wrongful death lawsuit, the drug makers knew or should have known about the nature and magnitude of the risk of harm associated with the design of Eliquis.

Catherine also claims that Pfizer and Bristol-Myers Squibb failed to provide proper warnings regarding all possible side effects with Eliquis use including the fact that a reversal agent does not exist for the drug.

An older anticoagulant drug, warfarin, while more complicated to monitor in a patient, has a reversal agent in the case of hemorrhage.

Eliquis and other similar new anticoagulants like Xarelto do not have medications to reverse the effects of the drug. Only recently has Pradaxa come out with a reversal agent, but Eliquis and Xarelto still do not have one.

This Eliquis Wrongful Death Lawsuit is Case No. 1:17-cv-03318-DLC in the United States District Court for the Northern District of Texas, Dallas Division.